Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome

Nasil Kong, Sunyoung Kim, Sang Chul Lee, Kyung Hee Park, Jae Hyun Lee, Jungwon Park

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Oral allergy syndrome (OAS) is the most common food allergy-related condition in adults. This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can improve the clinical symptoms of OAS in Korea. In total, 56 OAS patients were included: 19 subjects treated with SCIT, which included Fagales pollen extracts, and 37 not treated with immunotherapy (IT). We reviewed the patients' medical records and administered a telephone questionnaire at one point to assess baseline OAS features and changes in the patients' OAS and allergic rhinoconjunctivitis (ARC) symptoms after treatment. Only 12 patients who received SCIT and 15 patients that did not receive SCIT could report on changes in OAS symptoms after treatment because the other patients practiced strict avoidance of their culprit fruits and vegetables, and they could not respond to the status of OAS. SCIT reduced the severity of OAS (p=0.005). Nine of the 12 patients (75%) that received SCIT reported a more than 50% reduction in OAS symptoms. In contrast, only three of the 15 patients (20%) that did not receive IT reported more than a 50% reduction in OAS symptoms. SCIT also reduced the severity of ARC symptoms (p<0.001). The results indicate that SCIT with Fagales pollen-containing extracts is associated with improved OAS symptoms in Korea.

Original languageEnglish
Pages (from-to)389-394
Number of pages6
JournalYonsei medical journal
Volume60
Issue number4
DOIs
Publication statusPublished - 2019 Apr 1

Fingerprint

Pollen
Immunotherapy
Hypersensitivity
Korea
Food Hypersensitivity
Telephone
Vegetables
Medical Records
Fruit

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kong, Nasil ; Kim, Sunyoung ; Lee, Sang Chul ; Park, Kyung Hee ; Lee, Jae Hyun ; Park, Jungwon. / Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome. In: Yonsei medical journal. 2019 ; Vol. 60, No. 4. pp. 389-394.
@article{83c93c999e934aa98da85ff7f9e83063,
title = "Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome",
abstract = "Oral allergy syndrome (OAS) is the most common food allergy-related condition in adults. This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can improve the clinical symptoms of OAS in Korea. In total, 56 OAS patients were included: 19 subjects treated with SCIT, which included Fagales pollen extracts, and 37 not treated with immunotherapy (IT). We reviewed the patients' medical records and administered a telephone questionnaire at one point to assess baseline OAS features and changes in the patients' OAS and allergic rhinoconjunctivitis (ARC) symptoms after treatment. Only 12 patients who received SCIT and 15 patients that did not receive SCIT could report on changes in OAS symptoms after treatment because the other patients practiced strict avoidance of their culprit fruits and vegetables, and they could not respond to the status of OAS. SCIT reduced the severity of OAS (p=0.005). Nine of the 12 patients (75{\%}) that received SCIT reported a more than 50{\%} reduction in OAS symptoms. In contrast, only three of the 15 patients (20{\%}) that did not receive IT reported more than a 50{\%} reduction in OAS symptoms. SCIT also reduced the severity of ARC symptoms (p<0.001). The results indicate that SCIT with Fagales pollen-containing extracts is associated with improved OAS symptoms in Korea.",
author = "Nasil Kong and Sunyoung Kim and Lee, {Sang Chul} and Park, {Kyung Hee} and Lee, {Jae Hyun} and Jungwon Park",
year = "2019",
month = "4",
day = "1",
doi = "10.3349/ymj.2019.60.4.389",
language = "English",
volume = "60",
pages = "389--394",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "4",

}

Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome. / Kong, Nasil; Kim, Sunyoung; Lee, Sang Chul; Park, Kyung Hee; Lee, Jae Hyun; Park, Jungwon.

In: Yonsei medical journal, Vol. 60, No. 4, 01.04.2019, p. 389-394.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome

AU - Kong, Nasil

AU - Kim, Sunyoung

AU - Lee, Sang Chul

AU - Park, Kyung Hee

AU - Lee, Jae Hyun

AU - Park, Jungwon

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Oral allergy syndrome (OAS) is the most common food allergy-related condition in adults. This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can improve the clinical symptoms of OAS in Korea. In total, 56 OAS patients were included: 19 subjects treated with SCIT, which included Fagales pollen extracts, and 37 not treated with immunotherapy (IT). We reviewed the patients' medical records and administered a telephone questionnaire at one point to assess baseline OAS features and changes in the patients' OAS and allergic rhinoconjunctivitis (ARC) symptoms after treatment. Only 12 patients who received SCIT and 15 patients that did not receive SCIT could report on changes in OAS symptoms after treatment because the other patients practiced strict avoidance of their culprit fruits and vegetables, and they could not respond to the status of OAS. SCIT reduced the severity of OAS (p=0.005). Nine of the 12 patients (75%) that received SCIT reported a more than 50% reduction in OAS symptoms. In contrast, only three of the 15 patients (20%) that did not receive IT reported more than a 50% reduction in OAS symptoms. SCIT also reduced the severity of ARC symptoms (p<0.001). The results indicate that SCIT with Fagales pollen-containing extracts is associated with improved OAS symptoms in Korea.

AB - Oral allergy syndrome (OAS) is the most common food allergy-related condition in adults. This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can improve the clinical symptoms of OAS in Korea. In total, 56 OAS patients were included: 19 subjects treated with SCIT, which included Fagales pollen extracts, and 37 not treated with immunotherapy (IT). We reviewed the patients' medical records and administered a telephone questionnaire at one point to assess baseline OAS features and changes in the patients' OAS and allergic rhinoconjunctivitis (ARC) symptoms after treatment. Only 12 patients who received SCIT and 15 patients that did not receive SCIT could report on changes in OAS symptoms after treatment because the other patients practiced strict avoidance of their culprit fruits and vegetables, and they could not respond to the status of OAS. SCIT reduced the severity of OAS (p=0.005). Nine of the 12 patients (75%) that received SCIT reported a more than 50% reduction in OAS symptoms. In contrast, only three of the 15 patients (20%) that did not receive IT reported more than a 50% reduction in OAS symptoms. SCIT also reduced the severity of ARC symptoms (p<0.001). The results indicate that SCIT with Fagales pollen-containing extracts is associated with improved OAS symptoms in Korea.

UR - http://www.scopus.com/inward/record.url?scp=85063689038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063689038&partnerID=8YFLogxK

U2 - 10.3349/ymj.2019.60.4.389

DO - 10.3349/ymj.2019.60.4.389

M3 - Article

C2 - 30900426

AN - SCOPUS:85063689038

VL - 60

SP - 389

EP - 394

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 4

ER -